The Robert & Lynda Altman Family | Foundation Profile
GrantBay analyzes IRS Form 990-PF data to help grant seekers find fit funders like The Robert & Lynda Altman Family. Data shown is extracted from Form 990-PF filings.
EIN: 87-3339629
Foundation Overview
Based in Baltimore, MD, The Robert & Lynda Altman Family has awarded 19 grants totaling $33,078,420 to organizations in District of Columbia, Arizona and 1 other state across the US. Individual grants range from $50,000 to $4,325,684, with a median award of $1,254,800.
Latest Form 990-PF Snapshot
Foundation Intelligence
Advanced analytics and strategic insights to help nonprofit organizations assess grant opportunities and optimize their application strategies
New Applicant Friendliness
1 of 4 recipients (25%) were new grantees. Recent establishment means most partnerships are naturally new. Pattern may not reflect long-term preferences.
Geographic Focus
58% of grants are awarded in Arizona, with additional funding distributed across 2 other locations. The foundation balances regional focus with broader geographic diversity. Within Arizona, funding concentrates in Phoenix (100%).
Funding Trajectory
Moderate 31% growth trend over 1 years suggests stable and gradually increasing funding capacity. This positive trajectory indicates reliable grant-making resources and sustainable philanthropic commitment.
Program Areas
Dual focus on healthcare (50%) and general purposes, indicating strategic concentration in complementary program areas.
Where is The Money Going?
Grants & Funding
Analyzing past grantees provides valuable insights into The Robert & Lynda Altman Family's funding preferences, organizational priorities, and grant making patterns. This historical data helps potential applicants understand the foundation's strategic focus and identify successful funding approaches.
| Name | Amount | Location | Purpose | Year |
|---|---|---|---|---|
| Translational Genomics Research Institute Foundation | $3,022,490 | Phoenix, AZ, US | Establishment Of The Robert & Lynda Carter Altman Family Research Fund With Tgen And Its Affiliate, City Of Hope, To Facilitate Research Efforts In Two Complementary Areas Specifically Designed For Rapid Improvement Of Patient Outcomes Who Suffer From Mpn/saml. One Research Project, The Therapeutic Research Project, To Be Conducted By The City Of Hope Will Comprehensively Test And Scale Up The Manufacture Of The Drug Denominated As Mir-142. This "Mimetic" Drug Simulates (Replaces) The Action Of A Normal Signal That Is Missing In Mpn/saml Patients. | 2023 |
| Translational Genomics Research Institute Foundation | $2,651,826 | Phoenix, AZ, US | Establishment Of The Robert & Lynda Carter Altman Family Research Fund With Tgen And Its Affiliate, City Of Hope, To Facilitate Research Efforts In Two Complementary Areas Specifically Designed For Rapid Improvement Of Patient Outcomes Who Suffer From Mpn/saml. One Research Project, The Diagnostic Research Project, Is To Be Conducted By Tgen To Develop Two Diagnostic Tests. The First Diagnostic Research Project Is To Identify The Most Sensitive Test For The Transition From Mpn To Saml. The Second Diagnostic Research Project Is To Develop And Deploy An Ultra-rapid Whole Genomic Sequencing Test To Identify Drug Treatment Options For Patients Who Have Transitioned From Mpn To Saml. | 2023 |
| Smithsonian Institution | $200,000 | Washington, DC, US | General Purpose | 2023 |
| Matthew Silverman Memorial Foundation | $50,000 | Beverly Hills, CA, US | General Purpose | 2023 |
| Smithsonian Institution | $200,000 | Washington, DC, US | General Purpose | 2022 |
| Translational Genomics Research Institute Foundation | $4,325,684 | Phoenix, AZ, US | General Purpose | 2022 |
| Smithsonian Institution | $200,000 | Washington, DC, US | General Purpose | 2022 |
| Translational Genomics Research Institute Foundation | $3,070,884 | Phoenix, AZ, US | Establishment Of The Robert & Lynda Carter Altman Family Research Fund With Tgen And Its Affiliate, City Of Hope, To Facilitate Research Efforts In Two Complementary Areas Specifically Designed For Rapid Improvement Of Patient Outcomes Who Suffer From Mpn/saml. One Research Project, The Diagnostic Research Project, Is To Be Conducted By Tgen To Develop Two Diagnostic Tests. The First Diagnostic Research Project Is To Identify The Most Sensitive Test For The Transition From Mpn To Saml. The Second Diagnostic Research Project Is To Develop And Deploy An Ultra-rapid Whole Genomic Sequencing Test To Identify Drug Treatment Options For Patients Who Have Transitioned From Mpn To Saml. | 2022 |
| Translational Genomics Research Institute Foundation | $1,254,800 | Phoenix, AZ, US | Establishment Of The Robert & Lynda Carter Altman Family Research Fund With Tgen And Its Affiliate, City Of Hope, To Facilitate Research Efforts In Two Complementary Areas Specifically Designed For Rapid Improvement Of Patient Outcomes Who Suffer From Mpn/saml. One Research Project, The Therapeutic Research Project, To Be Conducted By The City Of Hope Will Comprehensively Test And Scale Up The Manufacture Of The Drug Denominated As Mir-142. This "Mimetic" Drug Simulates (Replaces) The Action Of A Normal Signal That Is Missing In Mpn/saml Patients. | 2022 |
| Smithsonian Institution | $200,000 | Washington, DC, US | General Purpose | 2022 |
| Translational Genomics Research Institute Foundation | $4,325,684 | Phoenix, AZ, US | General Purpose | 2022 |
| Smithsonian Institution | $200,000 | Washington, DC, US | General Purpose | 2022 |
| Translational Genomics Research Institute Foundation | $3,070,884 | Phoenix, AZ, US | Establishment Of The Robert & Lynda Carter Altman Family Research Fund With Tgen And Its Affiliate, City Of Hope, To Facilitate Research Efforts In Two Complementary Areas Specifically Designed For Rapid Improvement Of Patient Outcomes Who Suffer From Mpn/saml. One Research Project, The Diagnostic Research Project, Is To Be Conducted By Tgen To Develop Two Diagnostic Tests. The First Diagnostic Research Project Is To Identify The Most Sensitive Test For The Transition From Mpn To Saml. The Second Diagnostic Research Project Is To Develop And Deploy An Ultra-rapid Whole Genomic Sequencing Test To Identify Drug Treatment Options For Patients Who Have Transitioned From Mpn To Saml. | 2022 |
| Translational Genomics Research Institute Foundation | $1,254,800 | Phoenix, AZ, US | Establishment Of The Robert & Lynda Carter Altman Family Research Fund With Tgen And Its Affiliate, City Of Hope, To Facilitate Research Efforts In Two Complementary Areas Specifically Designed For Rapid Improvement Of Patient Outcomes Who Suffer From Mpn/saml. One Research Project, The Therapeutic Research Project, To Be Conducted By The City Of Hope Will Comprehensively Test And Scale Up The Manufacture Of The Drug Denominated As Mir-142. This "Mimetic" Drug Simulates (Replaces) The Action Of A Normal Signal That Is Missing In Mpn/saml Patients. | 2022 |
| Smithsonian Institution | $200,000 | Washington, DC, US | General Purpose | 2022 |
| Translational Genomics Research Institute Foundation | $3,070,884 | Phoenix, AZ, US | Establishment Of The Robert & Lynda Carter Altman Family Research Fund With Tgen And Its Affiliate, City Of Hope, To Facilitate Research Efforts In Two Complementary Areas Specifically Designed For Rapid Improvement Of Patient Outcomes Who Suffer From Mpn/saml. One Research Project, The Diagnostic Research Project, Is To Be Conducted By Tgen To Develop Two Diagnostic Tests. The First Diagnostic Research Project Is To Identify The Most Sensitive Test For The Transition From Mpn To Saml. The Second Diagnostic Research Project Is To Develop And Deploy An Ultra-rapid Whole Genomic Sequencing Test To Identify Drug Treatment Options For Patients Who Have Transitioned From Mpn To Saml. | 2022 |
| Translational Genomics Research Institute Foundation | $1,254,800 | Phoenix, AZ, US | Establishment Of The Robert & Lynda Carter Altman Family Research Fund With Tgen And Its Affiliate, City Of Hope, To Facilitate Research Efforts In Two Complementary Areas Specifically Designed For Rapid Improvement Of Patient Outcomes Who Suffer From Mpn/saml. One Research Project, The Therapeutic Research Project, To Be Conducted By The City Of Hope Will Comprehensively Test And Scale Up The Manufacture Of The Drug Denominated As Mir-142. This "Mimetic" Drug Simulates (Replaces) The Action Of A Normal Signal That Is Missing In Mpn/saml Patients. | 2022 |
| Smithsonian Institution | $200,000 | Washington, DC, US | General Purpose | 2022 |
| Translational Genomics Research Institute Foundation | $4,325,684 | Phoenix, AZ, US | General Purpose | 2022 |
Foundations Similar to The Robert & Lynda Altman Family
Discover 5 foundations with comparable assets ($233,037,670-$264,911,352), similar grant patterns, and geographic focus in MD that may also align with your organization's funding needs and grant seeking strategy.
| Foundation Name | Total Assets | Typical Grant Size | Service Area | Similarity Match |
|---|---|---|---|---|
|
Hector And Gloria Lopez Foundation
EIN: 81-4706788 | 29 grants awarded |
$258,260,970
(≈ Similar) |
$1,476,820
median grant |
Austin, TX |
|
|
William Maul Measey Trust
EIN: 94-6714956 | 35 grants awarded |
$233,194,862
(≈ Similar) |
$850,217
median grant |
Haverford, PA |
|
|
Cabin Road Foundation
EIN: 30-6284988 | 114 grants awarded |
$233,037,670
(≈ Similar) |
$996,860
median grant |
Redwood City, CA |
|
|
Broad Reach Foundation
EIN: 95-4861421 | 34 grants awarded |
$263,494,120
(≈ Similar) |
$2,000,000
median grant |
Boston, MA |
|
|
The Sunshine Charitable Foundation
EIN: 47-4535502 | 17 grants awarded |
$264,911,352
(≈ Similar) |
$2,100,000
median grant |
Campton, NH |
|
Related Foundation Resources in MD:
Contact Information
Official contact details for The Robert & Lynda Altman Family as registered with the IRS. These details are essential for grant applications, correspondence, and due diligence processes.
| EIN | 87-3339629 |
| Website | N/A |
| Address | 750 E PRATT ST 900 Baltimore, MD 21202-0000 |
Key People (5)
Board members, trustees, and key staff who oversee The Robert & Lynda Altman Family's grant making decisions and strategic direction. Understanding leadership composition can provide insights into foundation priorities and potential networking opportunities.
| Trustee | James Altman |
|---|---|
| Trustee | Jessica Altman |
| Trustee | Lynda Carter Altman |
| Disinterested Trustee | John Emerson |
| Disinterested Trustee | Marianne Schmitt Hellauer |
Forms 990-PF
IRS Form 990-PF filings provide comprehensive financial information, grant details, and operational data. These documents are essential resources for understanding foundation capacity, giving patterns, and strategic priorities.
Form 990-PF Research Tips
- Review Part XV for detailed grant recipient information and funding purposes
- Check Part I for total assets, annual giving amounts, and payout requirements
- Examine Part VIII for key personnel compensation and board structure
- Look for trends across multiple years to understand giving patterns
About This Foundation Profile
This comprehensive foundation profile for The Robert & Lynda Altman Family is powered by Grant Bay's advanced foundation research platform. Our system analyzes IRS Form 990-PF filings, grant histories, and philanthropic patterns to provide nonprofit organizations with actionable intelligence for grant seeking success.
Data Sources & Accuracy
All information is derived from official IRS filings and public records. Grant Bay processes thousands of Form 990-PF documents to extract grant details, financial data, and organizational information. Data accuracy depends on foundation reporting quality and IRS filing completeness.
Research Applications
Use this profile for prospect research, grant strategy development, application preparation, and relationship building. Combine this data with additional research on foundation priorities, application processes, and board member backgrounds for comprehensive grant seeking strategies.